N-acetyl-cysteine in combination with celecoxib inhibits Deoxynivalenol induced skin tumor initiation via induction of autophagic pathways in swiss mice
| Autor: | Somya Asthana, Sakshi Mishra, Sadan Kumar, Swati Chaturvedi, Srikanta Kumar Rath, D.K. Sharma, Jayant Dewangan, Aman Divakar, Sonal Srivastava, Muhammad Wahajuddin |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Skin Neoplasms Antioxidant medicine.medical_treatment Trichothecene Pharmacology Biochemistry Mice 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Physiology (medical) Autophagy Animals Medicine Adverse effect business.industry Therapeutic effect Glutathione medicine.disease Acetylcysteine 030104 developmental biology chemistry Celecoxib Skin cancer Trichothecenes business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Free Radical Biology and Medicine. 156:70-82 |
| ISSN: | 0891-5849 |
| Popis: | Deoxynivalenol is a trichothecene mycotoxin which naturally contaminates small grain, cereals intended for human and animal consumption. Investigations for dermal toxicity of DON has been needed and highlighted by WHO. Previous studies on dermal toxicity suggest that DON has DNA damaging potential leading to skin tumor initiation in mice skin. However, considering its toxicological manifestations arising after dermal exposure, strategies for its prevention/protection are barely available in literatute. Collectively, our study demonstrated that N-acetylcysteine (NAC), precursor of glutathione, significantly alters the genotoxic potential of DON. Further NAC in combination with Celecoxib (CXB) inhibits tumor growth by altering antioxidant status and increasing autophagy in DON initiated Swiss mice. Despite the broad spectrum use of CXB, its use is limited by the concerns about its adverse effects on the cardiovascular system. Serum parameters and histology analysis revealed that CXB (2 mg) when applied topically for 24 weeks did not impart any cardiovascular toxicity which could be because skin permeation potential of CXB was quite low when analyzed through HPLC analysis. Although the anticancer effects of CXB and NAC have been studied, however, the combination of NAC and CXB has yet not been explored for any cancer treatment. Therefore our observations provide additional insights into the therapeutic effects of combinatorial treatment of CXB and NAC against skin tumor prevention. This approach might form a novel alternative strategy for skin cancer treatment as well as skin associated toxicities caused by mycotoxins such as DON. This combinatorial approach can overcome the limitations associated with the use of CXB for long term as topical application of the same seems to be safe in comparison to the oral mode of administration. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect